Skip to main content
. 2017 Nov 20;5(7):904–908. doi: 10.3889/oamjms.2017.215

Table 1.

Summary of patient characteristics

Characteristic
Age (median, [range]) 60 years [24-78]
Tumor grade
  2 (n, %) 26 (32.1%)
  3 (n, %) 55 (67.9%)
Tumor stage
  IIIA (n, %) 9 (11.1%)
  IIIB (n, %) 24 (29.6%)
  IIIC (n, %) 45 (55.6%)
  IV (n, %) 3 (3.7%)
Residual disease
  ≤1cm (n, %) 29 (35.8%)
  >1cm (n, %) 52 (64.2%)
Platinum-free interval
  < 6 months 16 (19.8%)
  6-12 months 24 (29.6%)
  > 12 months 41 (50.6%)